KCT0000529已完成未知
Study of the Fimasartan effects on cardiovascular events and metabolic syndrome in patients with hypertension
Cheil General Hospital & Women's healthcare center0 个研究点目标入组 20,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 20(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1.Patients with hypertension who are 20 years old and higher and need angiotensin ? receptor blockers(ARBs), Fimasartan(Kanarb)
- •2.Patients who agreed to this study and handed out written consent forms
- •3.Patients who visited after fasting
排除标准
- •1. Patients who are currently taking Kanarb
研究者
相似试验
尚未招募
4 期
Protective effects of telmisartan on heart problems due to medicine (doxorubicin) in patients with breast cancerCTRI/2019/05/019245ICMR
已完成
不适用
Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECGLeft Ventricular HypertrophyHypertensionNCT03219632Seoul National University Bundang Hospital72
已完成
1 期
A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male VolunteersEssential HypertensionNCT00991783Boryung Pharmaceutical Co., Ltd14
已完成
不适用
The effect of Irbesartan for cardiac function in patients with atrial fibrillatioJPRN-UMIN000004607Kawasaki medical school, Division of cardiology50
终止
4 期
Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) StudyHypertensionNCT00140790Kumamoto University1,000